Chickenpox (Varicella-Zoster Virus - HHV-3)

Overview

Plain-Language Overview

Chickenpox (Varicella-Zoster Virus - HHV-3) is a common contagious infection that mainly affects the skin and causes an itchy rash with red spots and fluid-filled blisters. It primarily affects children but can occur at any age. The virus spreads through respiratory droplets or direct contact with the rash. The infection usually causes fever, tiredness, and discomfort before the rash appears. The rash typically starts on the face and trunk and then spreads to other parts of the body. Most people recover without complications, but the disease can be more severe in adults and immunocompromised individuals. After recovery, the virus remains dormant in nerve cells and can reactivate later in life as shingles.

Clinical Definition

Chickenpox is an acute, highly contagious disease caused by primary infection with Varicella-Zoster Virus (VZV), a member of the Herpesviridae family (HHV-3). The virus infects the respiratory mucosa and spreads hematogenously to the skin, producing a characteristic vesicular rash in multiple stages (macules, papules, vesicles, pustules, and crusts). The disease primarily affects the cutaneous and mucous membranes but can cause systemic symptoms such as fever and malaise. The hallmark of chickenpox is the presence of lesions in different stages of development simultaneously. The virus establishes latency in dorsal root ganglia, with potential reactivation as herpes zoster. Chickenpox is clinically significant due to its high transmissibility and potential for complications such as bacterial superinfection, pneumonia, and encephalitis, especially in immunocompromised hosts.

Inciting Event

Respiratory droplet exposure to infectious vesicle fluid or aerosolized virus initiates infection.
Close contact with a person actively shedding VZV during the contagious period triggers disease.
Exposure to fomites contaminated with VZV is a less common transmission route.

Latency Period

The incubation period from exposure to symptom onset is typically 10-21 days.
VZV remains latent in sensory ganglia for years to decades before possible reactivation.
Prodromal symptoms usually appear 1-2 days before rash onset.

Diagnostic Delay

Early rash may be mistaken for insect bites or other viral exanthems, delaying diagnosis.
Mild or atypical presentations in vaccinated individuals can lead to underrecognition.
Lack of awareness of recent exposure or vaccination status may cause diagnostic uncertainty.
Initial symptoms like fever and malaise are nonspecific, leading to delayed suspicion.

Clinical Presentation

Signs & Symptoms

Prodromal fever, malaise, and headache precede rash onset by 1-2 days.
Development of a pruritic, generalized vesicular rash that evolves through multiple stages simultaneously.
Lesions typically begin on the face and trunk before spreading to extremities.
Mild lymphadenopathy and sore throat may accompany the rash.
In children, symptoms are usually mild, whereas adults may experience more severe systemic symptoms.

History of Present Illness

Initial symptoms include fever, malaise, and headache followed by the appearance of a pruritic rash.
Rash progresses from macules to papules to vesicles and then crusts over within 4-7 days.
Lesions appear in successive crops over several days, resulting in lesions at different stages simultaneously.
Rash typically starts on the face and trunk and spreads centrifugally to extremities.
Associated symptoms may include anorexia, irritability, and mild respiratory symptoms.

Past Medical History

History of immunodeficiency or immunosuppressive therapy increases risk of severe disease.
Lack of prior varicella vaccination or previous varicella infection is relevant.
History of atopic dermatitis may predispose to more severe skin involvement.
Pregnancy status is important due to risk of complications.

Family History

Family members with recent varicella infection indicate potential exposure.
No known heritable genetic syndromes directly predispose to chickenpox.
Household clustering is common due to highly contagious nature of VZV.

Physical Exam Findings

Presence of a vesicular rash with lesions in various stages including macules, papules, vesicles, pustules, and crusts.
Lesions are typically pruritic and distributed centripetally, involving the trunk, face, and extremities.
Mucosal involvement with vesicles and ulcers in the oral cavity is common.
Fever and mild lymphadenopathy may be observed during the acute phase.
Diffuse erythema may precede the vesicular rash.

Diagnostic Workup

Diagnostic Criteria

Diagnosis of chickenpox is primarily clinical, based on the presence of a diffuse pruritic vesicular rash with lesions in various stages of evolution, accompanied by fever and constitutional symptoms. The rash typically begins on the face and trunk before spreading centrifugally. Confirmation can be obtained by direct fluorescent antibody testing or PCR of lesion samples to detect VZV DNA. Serologic testing for VZV IgM antibodies may support diagnosis in atypical cases. The characteristic clinical presentation with a history of exposure is usually sufficient for diagnosis.

Pathophysiology

Key Mechanisms

Primary infection with varicella-zoster virus (VZV, HHV-3) causes viremia and widespread infection of the skin and mucous membranes.
Latency of VZV occurs in dorsal root ganglia neurons after primary infection, allowing potential reactivation later.
Cell-mediated immunity controls viral replication and limits disease severity, with impaired immunity leading to more severe disease.
Viral replication in epidermal cells causes characteristic vesicular rash and systemic symptoms.
Immune complex formation and inflammation contribute to systemic symptoms such as fever and malaise.

Involvement	Details
Organs	Skin is the main organ affected, showing the classic pruritic vesicular rash.
	Lungs can be involved in severe cases causing varicella pneumonia, especially in adults and immunocompromised patients.
	Central nervous system may be affected in rare cases causing encephalitis or cerebellar ataxia.
Tissues	Epidermis is the primary site of viral replication and vesicle formation in chickenpox.
Tissues	Lymphoid tissue is involved in mounting the immune response to clear the virus.
Cells	T cells mediate cellular immunity critical for controlling varicella-zoster virus infection and preventing dissemination.
	Keratinocytes are infected by the virus, leading to characteristic vesicular skin lesions.
	Dendritic cells present viral antigens to initiate adaptive immune responses.
Chemical Mediators	Interferon-gamma is produced by activated T cells and enhances antiviral immunity against varicella-zoster virus.
Chemical Mediators	Cytokines such as IL-1 and TNF-alpha contribute to inflammation and fever during infection.

Treatments

Pharmacological Treatments

Acyclovir
- Mechanism:
  - Inhibits viral DNA polymerase after phosphorylation by viral thymidine kinase, preventing viral DNA replication.
- Side effects:
  - Nephrotoxicity
  - Headache
  - Nausea
- Clinical role:
  - First-line
Valacyclovir
- Mechanism:
  - Prodrug of acyclovir with improved oral bioavailability that inhibits viral DNA polymerase.
- Side effects:
  - Headache
  - Gastrointestinal upset
  - Elevated liver enzymes
- Clinical role:
  - First-line
Famciclovir
- Mechanism:
  - Prodrug converted to penciclovir that inhibits viral DNA polymerase.
- Side effects:
  - Headache
  - Nausea
  - Fatigue
- Clinical role:
  - Second-line
Varicella-zoster immune globulin (VZIG)
- Mechanism:
  - Provides passive immunity by supplying antibodies against varicella-zoster virus.
- Side effects:
  - Injection site reaction
  - Allergic reaction
- Clinical role:
  - Adjunctive

Non-pharmacological Treatments

Maintain skin hygiene and keep nails trimmed to prevent secondary bacterial infection of vesicles.
Use cool compresses and calamine lotion to relieve pruritus and discomfort.
Isolate infected individuals to prevent airborne transmission of varicella-zoster virus.

Prevention

Pharmacological Prevention

Varicella vaccine (live attenuated) is the primary pharmacological prevention for chickenpox.
Post-exposure prophylaxis with varicella vaccine within 3-5 days of exposure can prevent or attenuate disease.
Varicella-zoster immune globulin (VZIG) is used for high-risk exposed individuals who are unvaccinated or immunocompromised.

Non-pharmacological Prevention

Isolation of infected individuals to prevent airborne and contact transmission.
Hand hygiene and respiratory precautions to reduce spread of virus-laden droplets.
Avoiding contact with susceptible high-risk populations such as pregnant women and immunocompromised persons.
Screening for varicella immunity in healthcare workers and susceptible contacts.

Outcome & Complications

Complications

Varicella pneumonia is a serious complication, particularly in adults and immunocompromised individuals.
Bacterial superinfection of skin lesions leading to cellulitis or abscess formation.
Encephalitis and cerebellar ataxia can occur as neurologic complications.
Reye syndrome is a rare but severe complication associated with aspirin use during infection.
Disseminated varicella can occur in immunocompromised hosts causing multi-organ involvement.

Short-term Sequelae	Long-term Sequelae
Post-inflammatory hyperpigmentation or hypopigmentation at lesion sites. Secondary bacterial skin infections causing delayed healing and scarring. Dehydration due to fever and poor oral intake during acute illness. Transient thrombocytopenia may be observed during the acute phase.	Scarring from severe or secondarily infected skin lesions. Herpes zoster (shingles) due to reactivation of latent varicella-zoster virus in dorsal root ganglia. Postherpetic neuralgia following shingles in older adults or immunocompromised patients. Chronic neurologic deficits are rare but can result from varicella encephalitis.

Differential Diagnoses

Chickenpox (Varicella-Zoster Virus - HHV-3) versus Herpes Simplex Virus (HSV) Infection

Chickenpox (Varicella-Zoster Virus - HHV-3)	Herpes Simplex Virus (HSV) Infection
Pruritic vesicular rash progressing to crusted lesions in successive crops	Painful grouped vesicles on erythematous base, often localized
Single primary infection with widespread rash and subsequent latency	Recurrent episodes with localized outbreaks
Airborne transmission from respiratory droplets or vesicle fluid	Direct contact with active mucocutaneous lesions

Chickenpox (Varicella-Zoster Virus - HHV-3) versus Hand, Foot, and Mouth Disease (Coxsackievirus A16)

Chickenpox (Varicella-Zoster Virus - HHV-3)	Hand, Foot, and Mouth Disease (Coxsackievirus A16)
Generalized vesicular rash including trunk and face	Vesicles primarily on hands, feet, and oral mucosa
Common in children but can affect all ages	Common in children under 5 years
Fever with malaise and widespread pruritic rash	Mild fever and malaise with oral ulcers

Chickenpox (Varicella-Zoster Virus - HHV-3) versus Impetigo (Staphylococcus aureus or Streptococcus pyogenes)

Chickenpox (Varicella-Zoster Virus - HHV-3)	Impetigo (Staphylococcus aureus or Streptococcus pyogenes)
Vesicular rash evolving to crusted lesions	Honey-colored crusted erosions without vesicles
Viral infection confirmed by PCR or direct fluorescent antibody	Bacterial infection confirmed by culture
Requires antiviral therapy or supportive care	Rapid improvement with topical or systemic antibiotics

Chickenpox (Varicella-Zoster Virus - HHV-3) versus Scabies

Chickenpox (Varicella-Zoster Virus - HHV-3)	Scabies
Generalized vesicular rash with centrifugal spread	Burrows and papules in interdigital spaces, wrists, and genitalia
Pruritus often present but not characteristically nocturnal	Intense nocturnal pruritus
Detection of viral DNA by PCR or Tzanck smear showing multinucleated giant cells	Identification of mites or eggs on skin scraping

Chickenpox (Varicella-Zoster Virus - HHV-3) versus Erythema Multiforme

Chickenpox (Varicella-Zoster Virus - HHV-3)	Erythema Multiforme
Vesicular lesions progressing to crusted papules	Target lesions with central dusky area and concentric rings
Primary infection with varicella-zoster virus	Often triggered by HSV or medications
Viral illness with characteristic rash and potential for latency	Acute self-limited hypersensitivity reaction